Drug Profile
NCU 190
Alternative Names: NC 190; NCU 190NaLatest Information Update: 10 Nov 2006
Price :
$50
*
At a glance
- Originator Taisho Pharmaceutical
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 10 Nov 2006 Discontinued for Cancer in Japan (unspecified route)
- 07 Feb 2001 No-Development-Reported for Cancer in Japan (Unknown route)